Steven MC Chan
University of Toronto
H-index: 31
North America-Canada
Top articles of Steven MC Chan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in … | Haematologica | Tracy Murphy Jinfeng Zou Andrea Arruda Ting Ting Wang Zhen Zhao | 2024/2/2 |
TET2 Deficiency Increases the Competitive Advantage of Hematopoietic Stem Cells through Upregulation of Thrombopoietin Receptor Signaling | Steven Chan Yitong Yang Severine Cathelin Alex Liu Amit Subedi | 2024/3/25 | |
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation | Annals of Hematology | Josephine Lucero Muhned Alhumaid Igor Novitzky-Basso Jose-Mario Capo-Chichi Tracy Stockley | 2024/1/30 |
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN | Blood Advances | Marta B Davidson James A Kennedy Jose-Mario Capo-Chichi Yuliang Shi Wei Xu | 2024/3/12 |
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol | Leukemia | Maria Agustina Perusini Claire Andrews Atenafu G Eshetu Vikas Gupta Dawn Maze | 2024/3/2 |
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk … | Leukemia | Tracy Murphy Jacqueline M Mason Brian Leber Mark R Bray Steven M Chan | 2024/3 |
Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state | Steven Chan Mohsen Hosseini Veronique Voisin Ali Chegini Angelica Varesi | 2024/2/6 | |
Information-theoretic multi-time-scale partially observable systems with inspiration from leukemia treatment | Automatica | Margaret P Chapman Emily Jensen Steven M Chan Laurent Lessard | 2024/5/1 |
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L‐ASP: A retrospective analysis with an ASP‐based protocol in adult … | British Journal of Haematology | RuiQi Chen Eshetu G Atenafu Jack Seki Xing Liu Steven Chan | 2023/5 |
Somatic TET2 Mutations Prime the Immune System for Response to Immune Checkpoint Blockade | Blood | Robert Vanner Andy GX Zeng Michelle Chan-Seng-Yue Suraj Bansal Elisa Donato | 2023/11/28 |
Breakthrough invasive fungal infection after coadministration of venetoclax and voriconazole | Open Forum Infectious Diseases | Victoria G Hall Kenny Tang Deepali Kumar Coleman Rotstein Signy Chow | 2023/3/1 |
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly … | Acta Haematologica | Samantha A Hershenfeld Eshetu G Atenafu Steven Chan Vikas Gupta Dawn Maze | 2023/10/3 |
Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen | EJHaem | Ibrahim Al Nabhani Claire Andrews Jad Sibai Eshetu Atenafu Taylor Young | 2023/2 |
The Role of BCL-2/MCL-1 Targeting in Acute Myeloid Leukemia | Kenny Tang Steven M Chan | 2023/9/28 | |
Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia Patients with FMS3-like Tyrosine Kinase-3 Internal … | Blood | Josephine Anne Lucero Aniket Bankar Marta Beata Davidson Guillaume Richard-Carpentier Aaron D Schimmer | 2023/11/28 |
P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE | HemaSphere | Maria Agustina Perusini Vikas Gupta Aniket Bankar Jad Sibai Mark Minden | 2023/8/1 |
Uncovering the Role of CD59 As a Novel Therapeutic Target Against High-Risk Acute Myeloid Leukemia | Blood | Abdula Maher Steven M Chan | 2023/11/28 |
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis | European Journal of Haematology | Ram Vasudevan Nampoothiri Kenny Tang Andre Schuh Wilson Lam Dawn Maze | 2023/6 |
Final results of the phase Ib/II study evaluating enasidenib in combination with venetoclax in patients with IDH2-Mutated relapsed/refractory myeloid malignancies | Blood | Guillaume Richard-Carpentier Gopila Gupta Charina Cameron Severine Cathelin Aniket Bankar | 2023/11/28 |
Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia | Leukemia | Severine Cathelin David Sharon Amit Subedi Dan Cojocari Darren C Phillips | 2022/3 |
